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Abstract
Introduction
Epilepsy is one of the most common neurological diseases in Latin American Countries
(LAC) and epilepsy associated with convulsive seizures is the most frequent type. There-
fore, the detection of convulsive seizures is a priority, but a validated Spanish-language
screening tool to detect convulsive seizures is not available. We performed a field validation
to evaluate the accuracy of a Spanish-language questionnaire to detect convulsive seizures
in rural Bolivia using a three-stage design. The questionnaire was also administered face-
to-face, using a two-stage design, to evaluate the difference in accuracy.
Methods
The study was carried out in the rural communities of the Gran Chaco region. The question-
naire consists of a single screening question directed toward the householders and a confir-
matory section administered face-to-face to the index case. Positive subjects underwent a
neurological examination to detect false positive and true positive subjects. To estimate the
proportion of false negative, a random sample of about 20% of the screened negative under-
went a neurological evaluation.
Results
792 householders have been interviewed representing a population of 3,562 subjects
(52.2% men; mean age 24.5 ± 19.7 years). We found a sensitivity of 76.3% (95% CI 59.8–
88.6) with a specificity of 99.6% (95% CI 99.4–99.8). The two-stage design showed only a
slightly higher sensitivity respect to the three-stage design.
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Conclusion
Our screening tool shows a good accuracy and can be easily used by trained health workers
to quickly screen the population of the rural communities of LAC through the householders
using a three-stage design.
Introduction
Epilepsy is one of the most prevalent non communicable neurologic diseases, with an esti-
mated aggregate burden of around 0.7% of the total global disease burden [1]. It affects
approximately 70 million people worldwide [2] of whom live in low and middle-income coun-
tries (LMIC) where the treatment gap (TG) ranges from over 50% to 75% with higher levels
found in rural areas [3]. The higher prevalence and incidence rates of epilepsy in LMIC reflect
differences in several risk factors [4–9].
During the last decades, several epidemiological surveys have been carried out in LMIC to
estimate the prevalence of epilepsy, often using a two-stage design. In two-stage neuroepide-
miological studies, during the screening phase, the population is interviewed face-to-face
through the use of validated screening questionnaires and then evaluated by the specialists
[10]. However, this method is costly to implement in large populations since the first stage
takes considerable time and the second stage requires qualified medical personnel who often
have to assess a large number of false positive subjects.
Several screening instruments have been developed and validated, rarely in the field and
more often in a hospital context, to detect epilepsy in rural setting [11,12].
As recently highlighted by the WHO, the detection of epilepsy associated with convulsive
seizures (EACS) is a priority in rural areas of LMIC, since it is associated with higher comor-
bidity, injury and mortality than non-convulsive epilepsy [13,14]. Moreover, EACS can be eas-
ily identified by community health workers (CHW) because of their clear clinical
manifestations and consequently treated with relatively available drugs [15]. Furthermore,
minor seizures such as partial seizures are more difficult to detect at community-level [11,16].
Nevertheless, to the best of our knowledge, only two screening instruments have been devel-
oped in order to specifically detect convulsive epilepsy, showing a sensitivity between 48.6 and
72.1% with very high specificity level [17,18]. Both questionnaires have been developed to be
used in a three-stage design: in the first stage one or two preliminary questions are directed
toward a senior member of each household by a non-medical fieldworker; in a second confir-
matory phase, only people with a history of convulsions identified by the householders are
interviewed face-to-face by trained CHW, using a more detailed questionnaire; in the third
stage only the positive subjects at the second confirmatory phase undergo a clinical evaluation
in order to confirm the diagnosis. Such a design allows a reduction of cost and time related to
the face-to-face interview of the entire population.
It has been estimated that about 5 million people with epilepsy (PWE) live in Latin Ameri-
can Countries (LAC) [9], representing a considerable and often untreated health problem. In
this region the estimated median lifetime epilepsy (LTE) prevalence is 15.8/1,000 (10.7/1,000
for active epilepsy) with a median TG of 60.6% and 77.8% in the rural area [4]. In rural Bolivia
EACS is the most frequent type (about 60%) [16] and it is associated with the highest stigma
[19,20]. In the Gran Chaco area, the life-time prevalence of EACS is 7.2/1,000 (6.6/1,000 for
active EACS) with a crude incidence risk of 55.4/100,000 and a TG for active EACS of 70.2%
[21]. To the best of our knowledge, validated Spanish-language questionnaires for convulsive
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epilepsy are not available in the literature. It is known that the validity of a screening tool is
strictly dependent on the setting of use, so a questionnaire should be validated in the setting
where it will be used. We performed a field validation in the rural communities of the Gran
Chaco region in Bolivia of a Spanish-language screening questionnaire [18] to detect convul-
sive seizures using a three-stage design. The screening questionnaire is a slightly modified ver-
sion of the Anand’s tool. We have also evaluated the different accuracy of the screening
instrument when used in a two-stage or three-stage study design.
Methods
Study area and population
Bolivia is a low-middle-income country with high levels of poverty especially in rural areas,
where 40% of the population lives. The southeast region of Bolivia is part of the “Gran Chaco”,
a subtropical area also including Argentina and Paraguay. The ethnic group living in the study
area is mainly represented by native Guaranı´ people, living in poor dwellings located in rural
communities often reachable only by rural roads, without running water or electricity, and
with a local economy based on agriculture and animal husbandry. Most of the population
speaks both Spanish and Guaranı´. The study was carried out in two Departments of the Gran
Chaco region: the areas of Lagunillas and Gutierrez, located in the Cordillera Province,
Department of Santa Cruz de la Sierra and the areas of Huacaya and Machareti, located in the
Luis Calvo province, in the Department of Chuquisaca. A random sample of rural communi-
ties from these two different areas of the Gran Chaco region was selected using a cluster sam-
pling method, considering each community as a cluster, in order to achieve the required
sample size. We used as sampling list the “Censo de Poblacion y Vivienda 2012” [22].
Sample size calculation
The sample size was estimated according to the following formula, taking into account the
expected sensitivity of the questionnaire:
nS ¼
Z2a
2
S^ ð1   S^Þ
d2x Prev
Considering α = 0.05, Z α2 is inserted by 1.96; S and Prev are the pre-determined values of
sensitivity and prevalence of disease respectively and d2 is the precision of the estimate [23,24].
According to this formula, a sample size of 2,921 subjects was needed to reach 90% sensitivity
[11] with a precision of 13% and considering an EACS prevalence of 7.2/1,000 [21]. Further-
more, on the basis of previous population-based studies in the same area [16,19,21], a response
rate of 80% was expected, so in order to add a 20% of expected non- responders, 584 subjects
were added to the sample, reaching a total sample size of 3,505 subjects.
Screening tool
We used a modified Spanish version of the screening instrument developed by Anand et al.
[18]. The questionnaire was translated and modified with the help of a local Guaranı´ anthro-
pologist (SP) and the comprehension of the single items was pre-tested during a pilot study
carried out in two rural communities. The screening questionnaire consists of two sections
(S1 Table): the first section (stage I) is a single question administered to the householders (or
the most reliable person available in the family) enquiring about the presence of convulsive sei-
zures in one or more members of the family. The second section (stage II) is administered
face-to-face to the positive subjects identified during stage I and is composed by the same
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screening question administered to the householder plus six more specific confirmatory ques-
tions that explore symptoms related to tonic-clonic seizures. For subjects under 12 years of
age, or not available at the time of the screening phase, both stage I and II were indirectly per-
formed using a proxy responder.
Subjects who were found to be positive at at least one stage II question underwent a com-
plete neurological evaluation (stage III) for the confirmation of the diagnosis.
The questionnaires were administered by 18 Guaranı´ nursing students attending the last
year of their course at the Tekove Katu School, over the December 2015 and June 2016 period.
They had previously been trained for three days by three neurologists (one local neurologist
EBCG, and two Italian neurologists AN, CEC) at Tekove Katu School in the community of
Gutierrez in October 2015. The training focused on the clinical manifestations of convulsive
seizures with a comprehensive description and different video examples. They were also
trained to administer the questionnaire in two different sessions: at first, they administered the
questionnaires to each other and discussed their doubts with the neurologists and the anthro-
pologist. After that, they administered the questionnaire in a rural community under the
supervision of the neurologists and the anthropologist.
Validation phase
All positive subjects at the screening phase (stage I and II) underwent a neurological evaluation
in order to detect true positive (TP) and false positive (FP) subjects. The neurological examina-
tion (stage III) was performed in the field by three neurologists (one local neurologist EBCG
and two Italian neurologists LG, CEC). A member of the Asamblea del Pueblo Guaraní (APG),
who could speak Guaranı´, assisted in the field work. Convulsive seizures were defined accord-
ing to the 1993 ILAE definition. EACS was defined according to worldwide accepted WHO
definition as “a chronic brain disorder of various etiologies characterized by spontaneous
attacks of discontinuous contractions of the body musculature due to excessive discharge of
cerebral neurons” [25,26]. We used the 1981 classification of seizures [27]. In order to estimate
the proportion of false negative (FN) and true negative (TN) subjects, the neurologists evalu-
ated a random sample of about 20% of negative subjects, from a sample of randomly selected
communities. The neurologists were blinded for the previous results of the screening. The vali-
dation was performed in June 2016.
Furthermore, in order to compare the accuracy of the classic two-stage study design, in
which the questionnaire is administered face-to-face to the entire study population (except for
subjects less than 12 years of age), with the accuracy of the three-stage study design, the screen-
ing question was also administered face-to-face to all the adult subjects available at the time of
the screening. Thus, in this sample of subjects we evaluated the accuracy of both the two-stage
and the three-stage study design. The informed consent was obtained by the nursing students
during the screening phase, after a complete explanation of the study. Written consent was
obtained, whenever possible, using a Spanish language informed consent. In case of illiteracy
oral consent was obtained and a written list was used to record the subjects giving the consent.
The study was approved by the Bolivian Society of Neurology and by the ethics committee of
the University Hospital “Policlinico Vittorio Emanuele” of Catania, in Italy (41/2016/PO),
which also approved the consent procedure. The study was developed in accordance with the
STARD guidelines (S1 Checklist) [28].
Statistical analysis
The questionnaires were collected, coded, anonymized and entered in an ad-hoc created data-
base (Epidata 2.0.5.17) by a trained local worker. Data cleaning was also performed before the
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data analysis considering both range and consistency checks. Qualitative variables were
described as percentages and quantitative variables as mean ± standard deviation (SD). Sensi-
tivity, specificity, positive and negative predictive values (PPV and NPV) were calculated con-
sidering the three-stage design. In a sub-group of subjects we have also estimated the accuracy
of the two-stage design. The prevalence of convulsive seizures and EACS was calculated. Point
prevalence was estimated considering the 1st January 2016 as prevalence day. 95% confidence
intervals (CI) were estimated. Data were analyzed using STATA 12 software packages (version
12.0, College Station, TX).
Results
Validation
At the end of the study 792 householders had been gone through the stage I interview, repre-
senting a population of 3,562 subjects (1,860 men [52.2%]; mean age 24.5 ± 19.7 years), of
whom 1,118 (31.4%) were under 12 years of age. The proxy responders were represented by
mothers or wives for 2,185 cases (61.3%), fathers or husbands for 1,148 (32.2%), and others
such as grandparents, brothers or sisters for the remaining 229 subjects (6.5%). Overall 42 sub-
jects (1.2%) out of the 45 positive subjects at stage I, screened positive at stage II, of whom 29
were classified as TP and 13 as FP after the neurological evaluation, giving a prevalence for
convulsive seizures of 10.7/1,000 (95% CI 7.6–14.6). Among the TP subjects, 20 fulfilled the
diagnostic criteria for EACS giving a prevalence of 8.1/1,000, (95% CI 5.5–11.7), while six were
classified as febrile convulsions and three had had a single seizure.
Baseline characteristics of the study population are shown in Table 1. The validation process
is shown in Fig 1.
Table 1. Baseline characteristics of the subjects screened positive and negative after the two-stage design.
Screened positive Screened negative Total number
N = 42 N = 3,520 N = 3,562
N % N % N %
Sex (M) 25 59.5% 1,835 52.1% 1,860 52.2
Age (mean ± SD) 29.7 ± 20.8 24.4 ± 19.7 24.5 ± 19.7
Education
None 7 16.7 627 17.8 634 17.8
Primary 20 47.6 1,679 47.7 1,699 47.7
Secondary 12 28.6 1,049 29.8 1,061 29.8
Other 3 7.1 165 4.7 168 4.7
Occupation
Farmer 10 23.8 588 16.7 598 16.8
Housewife 6 14.3 765 21.7 771 21.6
Teacher 1 2.4 30 0.9 31 0.9
Health personnel 0 0 12 0.3 12 0.3
Other 25 59.5 2,125 60.4 2,150 60.4
Area
Gutierrez 8 19.0 408 11.6 416 11.7
Huacaya 22 52.4 1,247 35.4 1,269 35.6
Lagunillas 7 16.7 1,278 36.3 1,285 36.1
Machareti 5 11.9 587 16.7 592 16.6
N, number; SD, standard deviation.
https://doi.org/10.1371/journal.pone.0173945.t001
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In order to estimate the proportion of FN, of the 3,520 subjects (98.8%) screened negative
at the questionnaire, 739 (21%) subjects were randomly selected and underwent a neurological
evaluation. Out of the 739 subjects two (0.3%; 95% CI 0–0.6) were classified as FN. In particu-
lar, one was a 14-year-old boy suffering from generalized epilepsy with monthly tonic-clonic
seizures, started one year before while the second FN subject was a 15-year-old girl presenting
a partial epilepsy with secondary generalization with the last generalized tonic-clonic seizure
occurring more than five years before.
According to our sample proportion of FN (0.3%), in the whole sample (3,520 negative sub-
jects) nine subjects are expected to be FN, giving a sensitivity for the detection of convulsive
seizures of 76.3% (95% CI 59.8–88.6) and a specificity of 99.6% (95% CI 99.4–99.8) (Table 2).
Fig 1. Flow chart describing the validation process. TP, true positive; FP, false positive; TN, true
negative; FN, false negative. * expected values.
https://doi.org/10.1371/journal.pone.0173945.g001
Table 2. Values of accuracy of the questionnaire.
Best scenarioa Sensitivity % (95% CI) Specificity % (95% CI) PPV % (95% CI) NPV % (95% CI) TP FP TNc FNc
Three-stage design 76.3 (59.8–88.6) 99.6 (99.4–99.8) 69.0 (52.9–82.4) 99.7 (99.5–99.9) 29 13 3511 9
Worst scenariob Sensitivity % (95% CI) Specificity % (95% CI) PPV % (95% CI) NPV % (95% CI) TP FP TNc FNc
Three-stage design 58.0 (43.2–71.8) 99.6 (99.4–99.8) 69.0 (52.9–82.4) 99.4 (99.1–99.6) 29 13 3499 21
CI, confidence intervals; PPV, positive predictive value; NPV, negative predictive value; TP, true positive; FP, false positive; TN, true negative; FN, false
negative.
a False negative (n = 9) have been estimated on the basis of the sample proportion (0.3%).
b False negative (n = 21) have been estimated on the basis of the upper limit of the 95% CI of the sample proportion (0.6%).
c expected values.
https://doi.org/10.1371/journal.pone.0173945.t002
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However, considering the maximum number of expected FN subjects (n = 21), according
to the upper level of the 95% CI (0.6%), the worst scenario, the complete questionnaire
achieved a sensitivity of 58.0% (95% CI 43.2–71.8) with a specificity of 99.6% (95% CI 99.4–
99.8), as shown in Table 2.
The accuracy of each single confirmatory question of stage II are shown in Table 3.
Accuracy of the two-stage versus three-stage study design
The screening question was administered face-to-face to 1,434 adult subjects of the study pop-
ulation because 982 were not available at the time of the screening. Considering the two-stage
method and including in this analysis an overall population of 2,552 subjects, consisting of
1,434 adults who were directly interviewed and 1,118 subjects under 12 who could be only
indirectly interviewed, we obtained a sensitivity of 72.4% (95% CI 52.8–87.3), a specificity of
99.6% (95% CI 99.3–99.8) a PPV of 70.0% (95% CI 50.6–85.3) and a NPV of 99.7% (95% CI
99.4–99.9). In the same population of 2,552 subjects, when considering the three-stage design,
sensitivity was 68.0% (95% CI 46.5–85.0) specificity 99.8% (95% CI 99.5–99.9), PPV 73.9%
(95% CI 51.6–89.8) and NPV 99.7% (95% CI 99.4–99.9).
Discussion
During the last decades several screening questionnaires have been developed to detect PWE
in the general population, often using a two stage survey, in order to determine the prevalence
and incidence of epilepsy [11,29]. In two-stage surveys the population is screened with a ques-
tionnaire, often administered by trained CHW during the first phase and the diagnosis is con-
firmed by a neurological evaluation in the second phase [10]. Therefore, the choice of the
screening tool is a critical point in any epidemiological study, representing a potential pitfall.
Even if a perfect level of sensitivity and specificity is often difficult to achieve, and at any rate is
not required for a screening tool, the knowledge of the sensitivity and specificity is important
to quantify the potential inaccuracy of a screening test. For this reason, it is recommended to
use validated and standardized screening instruments and the validation of a screening ques-
tionnaire is a critical point. Therefore, the translation of a screening tool is a crucial process
that should always be undertaken with great care and ideally a translated questionnaire should
be re-validated in the setting in which it will be used.
A recent systematic review of screening questionnaires for epilepsy used in population-
based cohort studies has highlighted a high variability confirming the need for further high-
quality validation studies [29].
The detection of convulsive seizures is a priority in rural areas of LMIC. For this reason the
WHO has recently wondered if “convulsive epilepsy can be diagnosed at first level care by a non-
Table 3. Performances of the six confirmatory questions of the questionnaire.
Sensitivity % (95% CI) Specificity % (95% CI) PPV % (95% CI) NPV % (95% CI)
Question 1 50.0 (29.1–70.9) 66.7 (29.9–92.5) 80.0 (51.9–95.7) 33.3 (13.3–59.0)
Question 2 58.3 (36.6–77.9) 90.9 (58.7–99.8) 99.3 (68.0–99.8) 50.0 (27.2–72.8)
Question 3 76.0 (54.9–90.6) 58.3 (27.7–84.8) 79.2 (57.8–92.9) 53.8 (5.1–80.8)
Question 4 50.0 (29.9–70.1) 88.9 (51.7–99.7) 92.9 (66.1–99.8) 38.1 (18.1–61.6)
Question 5 82.6 (61.2–95.0) 10.0 (0.2–44.5) 67.9 (47.6–84.1) 20.0 (0.51–71.6)
Question 6 76.9 (56.3–91.0) 25.0 (5.5–57.2) 69.0 (49.2–84.7) 33.3 (7.5–70.1)
CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value.
https://doi.org/10.1371/journal.pone.0173945.t003
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specialist health care provider in LMIC settings” [11]. This question arises from the awareness
that EACS constitutes a greater health problem than non-convulsive epilepsy since it is associ-
ated with greater stigma and mortality [13,19,21]. Another important issue that arises in
detecting epilepsy in LMIC is “Who Would Be Questioned?” [30]. Usually in two-stage neuroe-
pidemiological studies, during the screening phase, a face-to-face interview is performed, with
high logistic and time costs. A suitable alternative can be represented by the administration of
the questionnaire to the householders using a three-stage design.
Up to date only two questionnaires have been developed and validated to detect convulsive
seizures (Table 4) [17,18].
Both tools, developed for a three-stage design, consist of one or two generic screening ques-
tions directed to the householder and a second confirmatory section directed to the index
case. Such design offers several advantages reducing the cost and timing related to the face-to-
face interview, but also allowing to reduce the number of false positive subjects, thus increasing
the specificity level at the second stage and reducing the number of subjects to be visited by the
neurologists, rarely available in these areas.
However, only the screening tool developed by Ngugi has been field validated in a rural
area reporting a quite low sensitivity of 48.6% with a specificity of 100% and an estimated cost
reduction of about 40% in respect to the two-stage design. According to the authors, the
stigma-related non-response could have been the main cause of the low sensitivity of the
three-stage design [17]. On the other hand, the questionnaire developed by Anand showed a
good sensitivity level of 72.1% with a specificity of 100% [18]. However, it was mainly validated
in a hospital setting and only a sample of patients and controls were enrolled at community
level. The generalization of estimates obtained by hospital-based validation is limited by selec-
tion bias due to the overrepresentation of cases with more severe forms of epilepsy and with a
greater awareness of the condition. Furthermore, in a hospital-based context, only subjects
who have been diagnosed will be enrolled, while people who lack knowledge of epilepsy may
fail to seek treatment and therefore are not captured in hospital-based validations. Thus, these
studies provide less accurate estimates than population-based validations [10,17]. For these
reasons in rural settings of LMIC the field validation method is probably the best way to per-
form a validation in order to develop a useful instrument, as much as adapted as possible to
the reality in which it will be used.
Although it has been estimated that about 5 million PWE live in LAC, no validated Spanish-
language questionnaire to detect convulsive seizures exists. We validated a Spanish-language
questionnaire to detect convulsive seizures in the rural population. Our instrument showed a
good level of sensitivity (76.3%) and specificity (99.6%) with values close to those obtained by
Anand. The higher level of sensitivity respect to the Ngugi questionnaire (48.6%) could be
probably due to the greater awareness among the Guaranı´ population of convulsive seizures
known as “manu-manu” in Guaranı´ language [16,19–21,31]. However we cannot exclude a
lower level of perceived stigma in our population [17].
Another important consideration arising from our study is related to the comparison of the
accuracy between the classic two-stage study design and the three-stage design. To the best of
Table 4. Characteristics of the existing questionnaires for convulsive seizures.
Study Country Language Target condition Validation Accuracy
Ngugi et al.
2012
Kenya Kigiriama Active epilepsy Field validation in a rural
setting
Sensitivity: 48.6% (95% CI 31.4–66.0); Specificity:
100%
Anand et al.
2005
India Indian Generalized tonic-clonic
seizures
Mixed field and hospital-based
validation
Sensitivity: 72.1% (95% CI 65.2–78.1); Specificity:
100% (95% CI 84–100)
https://doi.org/10.1371/journal.pone.0173945.t004
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our knowledge this is the first study in which such comparison has been made. Only one study
has previously assessed the concordance between the screening question when directed toward
the householder or directly administered, but considered different neurological disorders [30].
According to our findings, sensitivity achieved by the face-to-face interview in the two-stage
design was only slightly higher compared to the level achieved by the three-stage design
(72.4% versus 68.0%), while the level of specificity, PPV and NPV was almost the same. From
our point of view, the about 4 percentage points gained in the two-stage design do not justify
the difference in terms of cost and time.
Furthermore, in the two-stage design people who are not present at the time of the screen-
ing interview cannot be included in the study. In our study, in fact, we were able to perform a
face-to-face interview only for 1,434 adults because 982 were not available at the time of the
screening. Moreover, it should be underlined that in rural communities most men are farmer
who often work in the fields far from their house and can be away for a couple of months due
to seasonal works such as during the sugarcane harvesting time. However, we are aware that
this analysis is affected by the smaller size of the sample investigated that has led to less precise
estimates with a wider range of 95% CI.
Another important limit of our study is represented by the detection of false negative sub-
jects that has been performed just in a sample of about 20% of the screened negative subjects,
an approach already used by Placencia in Ecuador [10]. The neurological evaluation of the
entire screened population certainly represents the gold standard and would have been the
most suitable option, in order to perform a more reliable and complete validation. However,
in this rural setting neurologists are rarely available and the communities are spread out over a
large area often very far from one another, so the clinical evaluation of the entire screened pop-
ulation was not feasible due to cost and time reasons. Nevertheless, taking into account the
upper limit of the 95% CI, also considering the worst scenario, our sensitivity level is not lower
than 58.0% keeping a very high specificity level (99.6%).
Concerning the FN subjects, it is important to underline that they were missed both at stage
I and II, the direct and indirect interview respectively. One possible explanation could be in
one case the absence of tonic-clonic seizures for more than 5 years (thus considered non-active
EACS), while for the other case the recent onset of seizures, starting less than one year before.
It should be noted that for both cases the proxy responder at stage I was the father. As previ-
ously reported, men are often away from home and thus could not be totally aware regarding
family issues. On the other hand, according to our experience in rural communities, the moth-
ers are the most common (61.3%). and accurate proxy responders because they spend most of
their time at home and are better informed regarding the health status of their family
members.
In conclusion, our screening tool represents a valuable instrument, with an acceptable level
of sensitivity and excellent specificity that can be easily used, specially by trained health work-
ers, in order to quickly screen the entire population living in the rural communities of LAC
through the householders. Ideally, training all the community health workers, most subjects
affected by EACS living in the rural communities could be rapidly detected in order to imple-
ment an appropriate treatment strategy, as recommended by the WHO [11].
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